Results 1 to 10 of about 3,149 (178)

Hepatic alveolar echinococcosis simulating metastatic malignancy [PDF]

open access: yesAutops Case Rep
Echinococcosis is a parasitic disease caused by infection with tiny tapeworms of the genus Echinococcus. Echinococcosis is classified as either cystic echinococcosis or alveolar echinococcosis.
Mitra S   +4 more
europepmc   +4 more sources

Advances in the pharmacological treatment of hepatic alveolar echinococcosis: From laboratory to clinic. [PDF]

open access: yesFront Microbiol, 2022
Hepatic alveolar echinococcosis (HAE) is a zoonotic parasitic disease caused by the larvae of Echinococcus multilocularis. Because of its characteristics of diffuse infiltration and growth similar to tumors, the disability rate and mortality rate are ...
Xu X   +17 more
europepmc   +2 more sources

Kidney invasion occurred 2 years following liver transplantation for hepatic alveolar echinococcosis: a case report. [PDF]

open access: yesBMC Infect Dis, 2023
Background The organ most commonly invaded in echinococcosis is the liver; the lungs, brain, kidneys, heart, and spleen are rarely invaded, and multi-organ involvement in echinococcosis is even rarer.
Hu Q   +5 more
europepmc   +2 more sources

Hepatic alveolar echinococcosis: a diagnostic challenge

open access: yesJournal of the Belgian Society of Radiology, 2011
We report a case of alveolar echinococcosis involving the liver in a 61-year-old male. Alveolar echinococcosis is a rare chronic and progressive disease, which can involve mostly liver and in rare cases lung and brain.
O Yapici   +6 more
doaj   +5 more sources

Risk factor analysis and prediction of multi-organ metastasis in hepatic alveolar echinococcosis. [PDF]

open access: yesSaudi J Gastroenterol
Background: Patients with multiple organ metastases from hepatic alveolar echinococcosis have a high mortality rate. However, predictors of multi-organ metastasis have not been identified.
Xia P   +7 more
europepmc   +2 more sources

Progress and perspectives on BMP9-ID1 activation of HIF-1α and VEGFA to promote angiogenesis in hepatic alveolar echinococcosis. [PDF]

open access: yesFront Oncol
Hepatic alveolar echinococcosis is a zoonotic disease with a high incidence in western China, particularly affecting plateau areas such as Qinghai, Tibet, and Xinjiang.
Ke F, Xu MZ, Ma L, Chen QD, He BB, A JD.
europepmc   +2 more sources

Collateral circulation caused by end-stage hepatic alveolar echinococcosis. [PDF]

open access: yesBMC Infect Dis, 2023
Background Hepatic alveolar echinococcosis (HAE), as a benign parasitic disease with malignant infiltrative activity, grows slowly in the liver, allowing sufficient time for collateral vessels to emerge in the process of vascular occlusion.
Jiang T   +9 more
europepmc   +2 more sources

Surgical treatment strategies for hepatic alveolar echinococcosis

open access: yesFood and Waterborne Parasitology, 2019
Alveolar echinococcosis is a severe and rare helminthic disease with increasing incidence in endemic regions. Herein, available evidence on curative surgical and potential palliative approaches was reviewed.
L.A. Salm   +4 more
doaj   +4 more sources

Hepatic alveolar echinococcosis infection induces a decrease in NK cell function through high expression of NKG2A in patients. [PDF]

open access: yesFront Immunol
Echinococcus multilocularis larval tapeworm infection in humans is considered a serious public health issue. The immune interaction between parasites and their hosts is extremely important. NK cells are known innate immune cells that play important roles
Abulizi A   +11 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy